• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

117
26
24
17
15

COUNTRY

22
4
3
3
2

CATEGORIES

  • 87
  • 59
  • 44
  • 42
  • 38
  • 36
  • 24
  • 20
  • 17
  • 16
  • 14
  • 9
  • 7
  • 7
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

121
157
191
347

PUBLISHED

5
34
77
347

PRODUCT TYPE

224
77
40
3
3

Search "Cancer - Brain Tumor" returned 347 results.

PRODUCT TITLE
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

March 2015
FROM

Brain Cancer Treatment Drugs Markets in China

China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013" provides data on the Metastatic Brain...

February 2013
FROM

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012" provides data on the Metastatic...

January 2012
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

March 2015
FROM
Future Oncology: Technology, Products, Market and Service Opportunities Future Oncology: Technology, Products, Market and Service Opportunities - Product Thumbnail Image

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology is an analytical newsletter for executives, researchers, and market analysts in the pharmaceutical, biotechnology, financial, hospital and other health care industries. It provides comprehensive,...

April 2015

Brain Tumor - Pipeline Review, H2 2013

Brain Tumor - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

March 2015
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

March 2015
FROM

Brain Tumor – Pipeline Review, H1 2013

Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for Brain...

February 2013
FROM
Oncology Intelligence: A Comprehensive Report for Decision Making Oncology Intelligence: A Comprehensive Report for Decision Making - Product Thumbnail Image

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

January 2013
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

March 2015
FROM
Nanobiotechnology Applications, Markets and Companies Nanobiotechnology Applications, Markets and Companies - Product Thumbnail Image

Nanobiotechnology Applications, Markets and Companies

Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one billionth of a meter. Nanobiotechnology,...

March 2015
FROM
Cytogenetics - Technologies, Markets and Companies Cytogenetics - Technologies, Markets and Companies - Product Thumbnail Image

Cytogenetics - Technologies, Markets and Companies

This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular...

March 2015
FROM

Neuro-Oncology Part I, Vol 104. Handbook of Clinical Neurology

Handbook of Clinical Neurology: Neuro-Oncology, Part I summarizes the present state of scientific and clinical knowledge in the field of neuro-oncology, including information related to diagnostic techniques...

February 2012
Cancer Monoclonal Antibody Partnering Terms and Agreements Cancer Monoclonal Antibody Partnering Terms and Agreements - Product Thumbnail Image

Cancer Monoclonal Antibody Partnering Terms and Agreements

The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading...

August 2014
FROM
Cancer Vaccines: From First-in-Class to Best-in-Class? Cancer Vaccines: From First-in-Class to Best-in-Class? - Product Thumbnail Image

Cancer Vaccines: From First-in-Class to Best-in-Class?

This report gives you a new and unique way of stratifying and analyzing the global cancer vaccine pipeline and presents actionable analysis which allows you to discover: - Where the competition is;...

March 2013
FROM

Brain Metastasis - Pipeline Review, H2 2013

Brain Metastasis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Brain Metastasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM
Brain Cancer - Pipeline Review, H2 2012 Brain Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Brain Cancer - Pipeline Review, H2 2012

Brain Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Brain Cancer - Pipeline Review, H2 2012', provides an overview of the Brain Cancer therapeutic pipeline. This report provides...

August 2012
FROM

Cancer as a Metabolic Disease. On the Origin, Management, and Prevention of Cancer

The book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease...

July 2012
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.